Abbott Beats Q1 Profit and Revenue Estimates, But Cuts 2026 Outlook After $23B Exact Sciences Deal
Abbott beat Q1 earnings, boosted by cancer diagnostics deal, but cut 2026 profit outlook due to acquisition costs.
NOTRELOAD AI
Aehr Lands Massive $41M Follow-On Order from Top Hyperscale AI Customer
Aehr gets $41M AI chip testing order from big cloud customer, boosting demand for its systems as AI chip use grows fast.
Aligos Lands $445 Million China Deal for New Once-Daily Hepatitis B Pill
Aligos partners with Amoytop to bring a new hepatitis B drug to China, boosting cash and speeding access for millions of patients.
Citi Slams Flutter Entertainment with Double Downgrade to Sell Amid 2026 Growth Fears
Citi downgraded Flutter to Sell, slashed its price target, and warned of weak growth, rising competition, and falling profitability.
Strong AI Demand Helps TSMC Overlook Middle East Concerns, Lifts Outlook
Taiwan Semiconductor Manufacturing Company expects 30%+ growth as AI chip demand surges, despite risks from the Middle East conflict.
Jury Rules: Ticketmaster and Live Nation Are an Illegal Monopoly
US jury says Live Nation/Ticketmaster broke antitrust laws by controlling concerts. Fans paid more; judge will decide penalties.